InMed Pharmaceuticals Inc (INM)

[Stevemin]

"Some aspects of biological sample and data analyses will be delayed by COVID-19 pandemic-related restrictions and will impact the timing of announcing final study results"

So finally Adams has a "real" reason to delay further. He has to be smiling over this. However, years of kicking the can has now got him in a real pickle.

Biosynthesis = Delayed
EB PH1 = Delayed
Running out of money = Right on track (just wait until they announce the horribly dilutive deal to get some additional cash - its gonna be ugly)

With many CEO's foregoing their pay for the remainder of the year, I think it is reasonable to ask Mr. Adams to do the same.
Think he will? No chance!
He is going to keep getting paid because that's his only reason for being at Inmed. Its obvious he doesn't have any urgency to move real issues forward.